22-208
Showing 26 - 50 of 3,972
Predictive and Associated Factors of Musculoskeletal Injuries
Completed
- Musculoskeletal Injury
- Office Workers
-
Rawalpindi, Punjab, PakistanMTBC
Jan 31, 2023
Coronary Artery Disease, Platelet Reactivity Trial in Nieuwegein (Clopidogrel)
Not yet recruiting
- Coronary Artery Disease
- Platelet Reactivity
-
Nieuwegein, Utrecht, Netherlands
- +1 more
Dec 9, 2022
Uterine Fibroid Trial in New York (LIFE program)
Recruiting
- Uterine Fibroid
- LIFE program
-
New York, New YorkNYU Langone Health
Jan 10, 2023
Immunomodulators Associated With Atrial Fibrillation Reporting:
Completed
- Atrial Fibrillation
- Immunomodulators with FDA approval on the 1st January 2023.
-
Caen, Basse Normandie, FranceAlexandre Joachim
Oct 17, 2023
Macrophage PET/CT Imaging Using 64Cu-DOTATATE for Diagnosis of
Recruiting
- Cardiac Sarcoidosis
- 64Cu-DOTATATE PET/CT scan
-
Copenhagen, DenmarkRigshospitalet
Nov 14, 2023
Influenza, Human, COVID-19 Trial in United States (bivalent BNT162b2 (original/Omi BA.4/BA.5), qIRV (22/23), QIV)
Recruiting
- Influenza, Human
- COVID-19
- bivalent BNT162b2 (original/Omi BA.4/BA.5)
- +2 more
-
Athens, Alabama
- +18 more
Dec 22, 2022
Androgenetic Alopecia Trial in Seoul (AD-208, AD-2081, of AD-208)
Recruiting
- Androgenetic Alopecia
- AD-208
- +3 more
-
Seoul, Korea, Republic ofThe Catholic University of Korea, Eunpyeong St. Mary's Hospital
Nov 11, 2021
Neutropenia, Breast Cancer Trial in Canada, Korea, Republic of, United States (SPI-2012, Pegfilgrastim, Docetaxel)
Itch Trial in Aalborg (CA and BAM8-22, Vehicle and BAM8-22 application, CA)
Completed
- Itch
- CA and BAM8-22
- +3 more
-
Aalborg, DenmarkAalborg University
Sep 7, 2023
Type 2 Diabetes Trial in Worldwide (Tirzepatide, Antihyperglycemic medication)
Not yet recruiting
- Type 2 Diabetes
- Tirzepatide
- Antihyperglycemic medication
-
Birmingham, Alabama
- +96 more
Aug 8, 2022
Iliotibial Band Syndrome Trial in Lahore (Manual myofascial release, Emmett intervention)
Completed
- Iliotibial Band Syndrome
- Manual myofascial release
- Emmett intervention
-
Lahore, PakistanRiphah IU
Jul 14, 2022
MR Evidence of Cardiac Inflammation Post-Stroke
Recruiting
- Stroke, Ischemic
- +2 more
- Gadolinium-enhanced cardiac MRI
- +2 more
-
London, Ontario, CanadaHeart & Brain Lab, Western University
Feb 8, 2023
Large Hole Percutaneous Arterial Closure Trial (PerQseal ELITE)
Not yet recruiting
- Large Hole Percutaneous Arterial Closure
- PerQseal ELITE
- (no location specified)
Jul 10, 2023
Advanced Lung Adenocarcinoma, Advanced Lung Adenosquamous Carcinoma, Advanced Lung Non-Small Cell Carcinoma Trial in United
Recruiting
- Advanced Lung Adenocarcinoma
- +10 more
- Carboplatin
- +10 more
-
Phoenix, Arizona
- +98 more
Feb 2, 2023
Chronic Lymphocytic Leukemia Trial in Portland (drug, procedure, biological, other)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Acalabrutinib
- +8 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 12, 2023
Glioblastoma Multiforme, Anaplastic Astrocytoma, Fibrillary Astrocytomas Trial in Miami (SIACI of cetuximab and bevacizumab)
Not yet recruiting
- Glioblastoma Multiforme
- +4 more
- SIACI of cetuximab and bevacizumab
-
Miami, FloridaJackson Memorial Hospital
Jul 14, 2023
Assessment of Maximal Oxygen Uptake in Cardiac Rehabilitation
Completed
- Oxygen Consumption
- measurement of oxygen uptake
-
Aarhus N, DenmarkClaus Sevel
Oct 30, 2023
Telerehabilitation for TMD
Recruiting
- Temporomandibular Disorder
- +5 more
- Telerehabilitation
-
Minneapolis, MinnesotaUniversity of Minnesota
Jun 21, 2022
Malaria Trial in Kampala (Transfluthrin - delivery by paid study personnel, Transfluthrin - delivery by voucher system,
Not yet recruiting
- Malaria
- Transfluthrin - delivery by paid study personnel
- +2 more
-
Kampala, Uganda
- +1 more
Nov 7, 2023
Pregnancy, Iron Deficiency Trial in Vancouver (Ferrous fumarate, Ferrous bisglycinate)
Not yet recruiting
- Pregnancy
- Iron Deficiency
- Ferrous fumarate
- Ferrous bisglycinate
-
Vancouver, British Columbia, CanadaUniversity of British Columbia, Food, Nutrition and Health Build
Aug 25, 2023
Type 1 Diabetic Nephropathy Trial in Cairo (oral sitagliptin supplementation)
Completed
- Type 1 Diabetic Nephropathy
- oral sitagliptin supplementation
-
Cairo, EgyptNancy Elbarbary
Nov 2, 2023